Search Results

You are looking at 1-10 of 39

Drug Therapy in Dental Practice: Nonopioid and Opioid Analgesics
Daniel E. BeckerDDS and
James C. PheroDMD
Article Category: Other
Volume/Issue: Volume 52: Issue 4
Online Publication Date: Jan 01, 2005
Page Range: 140 – 149

. Figure 1. Nociceptive pathways. The drawing illustrates [A] incoming nociceptive impulses, [B] ascending nociceptive tracks, and [C] descending inhibitory tracts that act to blunt incoming pain signals. Abbreviations represent the myriad of neurotransmitters that contribute to pain transmission. They reflect potential targets for pharmacologic intervention to control pain. Conventional analgesics are classified as opioids and nonopioids, but the older terms ‘‘narcotic’’ and ‘‘non-narcotic’’ continue to be used interchangeably. Current research has

Download PDF
Daniel E. Becker
Figure 2
Figure 2

Analgesic efficacy. This graph illustrates a typical dose-response curve for orally administered (PO) analgesics. The dose-response curve for opioids such as morphine demonstrates unlimited efficacy in which greater doses provide greater analgesia. At equipotent doses, all opioids demonstrate a similar dose response. In contrast, nonopioids demonstrate a “ceiling” effect that generally is adequate for relief of mild to moderate pain (pain relief rating of 4–5 in this scale). For ibuprofen, doses greater than 400 mg do not provide further analgesia. For aspirin (ASA) and acetaminophen (APAP), this ceiling effect is achieved at 1000 mg and is somewhat lower than that provided by nonsteroidal anti-inflammatory drugs (NSAIDs).


Daniel E. Becker and
James C. Phero
Figure 1
Figure 1

Nociceptive pathways. The drawing illustrates [A] incoming nociceptive impulses, [B] ascending nociceptive tracks, and [C] descending inhibitory tracts that act to blunt incoming pain signals. Abbreviations represent the myriad of neurotransmitters that contribute to pain transmission. They reflect potential targets for pharmacologic intervention to control pain.


Daniel E. Becker and
James C. Phero
Figure 2
Figure 2

Synthesis and functions of prostanoids.


Daniel E. Becker and
James C. Phero
Figure 3
Figure 3

Molecular structures of morphine, codeine, and derivatives. Codeine and its derivatives differ from their morphine-derived counterparts only in a methyl substitution (circled). This methyl group prevents adequate binding to the mu opioid receptor that mediates most opioid effects. However, these prodrugs are capable of producing nausea and constipation, which are problematic when high doses are administered to generate enough active metabolite for analgesia. (Asterisks indicate molecular alterations from morphine and codeine.)


Daniel E. BeckerDDS
Article Category: Research Article
Volume/Issue: Volume 57: Issue 2
Online Publication Date: Jan 01, 2010
Page Range: 67 – 79

pain interpretation. These agents have marginal benefit in the management of acute pain, and they are not regarded as “analgesics” in the conventional sense. Management of chronic pain will be the topic of a subsequent continuing education article in this journal. Analgesics are classified as opioids and nonopioids, but dated terms like narcotic and non-narcotic are used interchangeably. Formerly, it was believed that opioids acted only within the brain and spinal cord, but the action of nonopioids was confined to the periphery (ie, the site of injury

Rodney N Nishimoto
Article Category: Other
Volume/Issue: Volume 61: Issue 3
Online Publication Date: Jan 01, 2014
Page Range: 99 – 102

Effective treatment of acute postoperative dental pain often requires a multimodal pain management approach—the use of multiple complementary analgesics with different mechanisms and sites of action—as a means of optimizing analgesic efficacy and reducing opioid-related adverse effects. 1 , 2 The American Society of Anesthesiologists Task Force on Acute Pain Management advocates that unless contraindicated, patients should receive an around-the-clock regimen of nonopioid analgesics as first-line agents and for opioids to be used as

Joel M. Weaver DDS, PhD
Article Category: Other
Volume/Issue: Volume 60: Issue 2
Online Publication Date: Jan 01, 2013
Page Range: 35 – 36

are all risk factors for OSA. Every preoperative evaluation therefore should include documentation of our estimation of the patient's risk for OSA. There is sound evidence that nonsteroidal anti-inflammatory analgesics and acetaminophen provide excellent postoperative analgesia and should be considered for all children who are at risk for OSA, even if they have not been diagnosed with it. We need to consider the risk:benefit ratio of prescribing opioids versus nonopioid alternatives for all children and especially for those at risk for OSA, since opioids

Dr Earle R. YoungBSc, DDS, BScD, MSc, FADSA
Article Category: Book Review
Volume/Issue: Volume 52: Issue 1
Online Publication Date: Mar 01, 2005
Page Range: 42 – 43

pathophysiology (peripheral sensitization, central sensitization, and neuronal plasticity), and the categories of pain (ie, nociceptive [somatic and visceral] and neuropathic pain). Chapter 4 discusses a brief, practical overview of a range of nonpharmacological approaches to pain management: transcutaneous electrical nerve stimulation, acupuncture, thermal therapy, massage, exercise, and behavioral and cognitive therapy. Chapter 5 discusses nonopioid analgesics. Several points of interest include the analgesic actions of acetaminophen involving the nitric oxide

Eliezer KaufmanDMD,
Joel B. EpsteinDMD, MSD, FRDC(C),
Meir GorskyDMD,
Douglass L. JacksonDMD, MS, PhD, and
Avishag KadariMD
Article Category: Research Article
Volume/Issue: Volume 52: Issue 1
Online Publication Date: Mar 01, 2005
Page Range: 29 – 38

, relying on the release of nonopioid neurotransmitters and the activation of nonopioid receptors at the spinal and medullary dorsal horn. The existence and expression of opioid receptors is related to the function of endogenous opioid peptides (ie, enkephalins, endomorphins, dynorphins, and endorphins), which are capable of modulating pain. Similar to the inhibitory actions of exogenously administered opioids in the CNS, the endogenous opioid peptides also decrease the amount of excitatory neurotransmitter release from the central terminals of nociceptive